Cfo4 Life Group, LLC Novo Nordisk A S Transaction History

Cfo4 Life Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$122.71 - $146.91 $90,682 - $108,566	-739 Reduced 27.41%	1,957 $279,000
Q1 2024 May 06, 2024	BUY	$102.11 - $135.92 $43,396 - $57,765	425 Added 18.71%	2,696 $346,000
Q4 2023 Jan 24, 2024	SELL	$87.78 - $105.45 $7,549 - $9,068	-86 Reduced 3.65%	2,271 $234,000
Q3 2023 Oct 30, 2023	BUY	$90.94 - $199.54 $214,345 - $470,315	2,357 New	2,357 $214,000

1,956

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $239B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cfo4 Life Group, LLC with notifications on news.